期刊文献+

A Cross Sectional Study on the Correlation between Waist Circumference and Fatty Liver on Ultrasonography among Non-Alcoholic Filipino Adults

A Cross Sectional Study on the Correlation between Waist Circumference and Fatty Liver on Ultrasonography among Non-Alcoholic Filipino Adults
下载PDF
导出
摘要 Objectives: This study aimed to determine the correlation between waist circumference and fatty liver on ultrasonography among non-alcoholic Filipino adults. This will aid in detecting non-alcoholic fatty liver disease in its early course, hence improving our current therapeutic recommendations in preventing and managing the adverse health outcomes of NAFLD. Methods and Materials: A cross-sectional study with a total of 65 recruited participants. The data collected were age, sex, waist-circumference, co-morbidities with maintenance medications, history of alcohol intake with emphasis on the quantity and duration, and history of drug intake. Waist circumference was measured and recorded. The presence of NAFLD was determined through a review of the ultrasonography results of all subjects. The demographic profile and waist circumference of all subjects were described using descriptive statistics. The chi-square test was utilized to test the independence of the NAFLD and WC in the quartile. Pearson correlation was used to determine the linear relationship between the variables. Pearson correlation coefficient was statistically significant at p 0.05. Results: Among the subjects, 26 (42%) presented with fatty liver based on ultrasonography, 15 (58%) and 11 (42%), males and females, respectively. The mean waist circumference of 97.5 ± 12.43 was significantly related to the fatty liver with a p-value of 0.0001. Waist circumference showed a positive correlation with the frequency of fatty liver on ultrasonography with p-values of 0.000755 (r = 0.590083) and 3.04366E—05 (r = 0.659143523), in males and females, correspondingly. The overall correlation between waist circumference and fatty liver on ultrasonography is statistically significant with a p-value of 4.10503E—08 (r = 0.634737127). Conclusion: One measure used to assess central obesity is waist circumference. In addition, it can also be utilized to assess risk for NAFLD since they are strongly correlated as reported in this study. Waist circumference cut-off values for the Filipinos proposed in this study are the following: >88 cm and >95 cm, in males and females, respectively. Objectives: This study aimed to determine the correlation between waist circumference and fatty liver on ultrasonography among non-alcoholic Filipino adults. This will aid in detecting non-alcoholic fatty liver disease in its early course, hence improving our current therapeutic recommendations in preventing and managing the adverse health outcomes of NAFLD. Methods and Materials: A cross-sectional study with a total of 65 recruited participants. The data collected were age, sex, waist-circumference, co-morbidities with maintenance medications, history of alcohol intake with emphasis on the quantity and duration, and history of drug intake. Waist circumference was measured and recorded. The presence of NAFLD was determined through a review of the ultrasonography results of all subjects. The demographic profile and waist circumference of all subjects were described using descriptive statistics. The chi-square test was utilized to test the independence of the NAFLD and WC in the quartile. Pearson correlation was used to determine the linear relationship between the variables. Pearson correlation coefficient was statistically significant at p 0.05. Results: Among the subjects, 26 (42%) presented with fatty liver based on ultrasonography, 15 (58%) and 11 (42%), males and females, respectively. The mean waist circumference of 97.5 ± 12.43 was significantly related to the fatty liver with a p-value of 0.0001. Waist circumference showed a positive correlation with the frequency of fatty liver on ultrasonography with p-values of 0.000755 (r = 0.590083) and 3.04366E—05 (r = 0.659143523), in males and females, correspondingly. The overall correlation between waist circumference and fatty liver on ultrasonography is statistically significant with a p-value of 4.10503E—08 (r = 0.634737127). Conclusion: One measure used to assess central obesity is waist circumference. In addition, it can also be utilized to assess risk for NAFLD since they are strongly correlated as reported in this study. Waist circumference cut-off values for the Filipinos proposed in this study are the following: >88 cm and >95 cm, in males and females, respectively.
作者 Arriza Kryssan S. Monjardin-Soria Arriza Kryssan S. Monjardin-Soria(Chong Hua Hospital, Cebu City, Philippines)
机构地区 Chong Hua Hospital
出处 《Open Journal of Endocrine and Metabolic Diseases》 CAS 2023年第1期1-16,共16页 内分泌与新陈代谢疾病期刊(英文)
关键词 Non-Alcoholic Fatty Liver Waist Circumference NAFLD Non-Alcoholic Fatty Liver Waist Circumference NAFLD
  • 相关文献

参考文献1

二级参考文献31

  • 1[1]Silverman JF,Pories WJ,Caro JF.Liver pathology in diabetes mellitus and morbid obesity.Clinical,pathological,and biochemical considerations.Pathol Annu 1989;24:275-302
  • 2[2]Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology 2003;37:1202-1219
  • 3[3]Angulo P.Nonalcoholic fatty liver disease.N Engl J Med 2002;346:1221-1231
  • 4[4]Wanless IR,Lentz JS.Fatty liver hepatitis(steatohepatitis)and obesity:an autopsy study with analysis of risk factors.Hepatology 1990;12:1106-1110
  • 5[5]Ruhl CE,Everhart JE.Epidemiology of nonalcoholic fatty liver.Clin Liver Dis 2004;8:501-519,vii
  • 6[6]Angulo P.Treatment of nonalcoholic fatty liver disease.Ann Hepatol 2002;1:12-19
  • 7[7]Nair S,Diehl AM,Wiseman M,Farr GH Jr,Perrillo RP.Mefformin in the treatment of non-alcoholic steatohepatitis:a pilot open label trial.Aliment Pharmacol Ther 2004;20:23-28
  • 8[8]Bugianesi E,Gentilcore E,Manini R,Natale S,Vanni E,Villanova N,David E,Rizzetto M,Marchesini G.A randomized controlled trial of mefformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.Am J Gastroenterol 2005;100:1082-1090
  • 9[9]Ueno T,Sugawara H,Sujaku K,Hashimoto O,Tsuji R,Tamaki S,Torimura T,Inuzuka S,Sata M,Tanikawa K.Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.J Hepatol 1997;27:103-107
  • 10[10]Hickman IJ,Jonsson JR,Prins JB,Ash S,Purdie DM,Clouston AD,Powell EE.Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase,fasting insulin,and quality of life.Gut 2004;53:413-419

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部